Depletion of sinusoidal endothelial cell glutathione (GSH) has been proposed as a common mechanism leading to hepatic veno-occlusive disease (HVOD). This study examines whether intraportal infusion of GSH can prevent HVOD in the monocrotaline rat model. HVOD was induced in rats with monocrotaline 16
On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease
✍ Scribed by E. Carreras; A. Grañena; M. Navasa; M. Bruguera; V. Marco; J. Sierra; M. D. Tassies; J. C. García-Pagán; J. M. Martí; J. Bosch; J. Rodés; C. Rozman
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 401 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Days 0 7 14 21 Chemotherapy VCR (1.5 mg/m 2 ) \* \* \* \* Dactinomycin (15 g/m 2 ) \*
## Introduction. Hepatotoxicity consistent with the clinical diagnosis of veno-occlusive disease (VOD) of the liver has been suspected after conventional anti-cancer chemotherapy in children. Methods. To establish the incidence of hepatotoxicity and its relationship with VOD, we analyzed toxicity
## Abstract Veno‐occlusive disease (VOD) of the liver is an extremely rare complication of azathioprine (AZT) use in patients with kidney transplants (KTs). Although VOD is frequently seen in bone marrow transplant patients, so far only 24 cases have been reported in KT patients. Our case adds to t
## Hepatic veno-occlusive disease (VOD) is a common transplant-related complication of stem cell transplantation. There is no safe and proven therapy for established VOD, and attempts have focused on its prevention. Limited studies have suggested that prophylactic use of ursodeoxycholic acid (UDCA)